BMS to Acquire MyoKardia
We announced our agreement to acquire MyoKardia, whose portfolio of pipeline drug candidates includes mavacamten, a potential first-in-class medicine that shows compelling data in the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy. Click here for an overview.
Global Patient Week
Our week-long patient celebration allows us to reconnect with our mission, celebrate and honor the patients we have helped, strive to do more for the patients who do not yet have an answer and share our inspiration and motivation with the world.
Survivorship Today
Emmy winner Sterling K. Brown explores cancer survivorship during a global pandemic.
Moving forward.
Together.
Careers
We’re looking for people who want to change lives. Join us as we transform patients’ lives through science.
Investors
Learn more about how we strive to produce sustained strong performance and shareholder value.
Looking for Answers?
Quick links to helpful resources.
Clinical Trial Information for Researchers
Medical Information for Healthcare Providers
Help Paying for Your Medicines